|
|
Horizon Pharma, Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: MS Presentation 9/13/18Getting to better multiple makes sense. However what's missing is the sale of primary care business. I suspect that they are still looking to sell that business but have not found a buyer yet. Based on last quarter's primary care performance we can see a decline in PC revenue due to a realignment of sales resources and focus on rheumo and orphan business. The good news is the fears about drug pricing controls seem to have subsided, making a sale of the PC business less problematic. |
||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 1446 | Re: MS Presentation 9/13/18 | geringerart | 0 | 9/14/2018 2:40:08 PM |
| 1447 | Re: MS Presentation 9/13/18 | drugfree | 0 | 9/14/2018 5:53:43 PM |
